Page 9 - Processa Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hanover, MD., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) announced today with great sadness that Virgil Thompson,...

HANOVER, MD, Oct. 13, 2023 -- Processa Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy...

Interim analysis of Phase 1B data suggests Processa’s novel chemotherapy treatment could improve safety and efficacy in more patients by individualizing the dosing regimen for each patient ...

Processa Pharmaceuticals, Inc. announces that industry veteran George Ng has been appointed to serve as the Company's Chief Executive Officer and as a Board Director as of August 8, 2023. Dr. David...

Processa Pharmaceuticals (NASDAQ:PCSA – Get Free Report) and BetterLife Pharma (OTCMKTS:BETRF – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, valuation, risk, analyst recommendations and institutional ownership. Earnings & Valuation This table compares Processa […]